<DOC>
	<DOCNO>NCT00096213</DOCNO>
	<brief_summary>RATIONALE : Intralesional resection less invasive type surgery chondrosarcoma bone may fewer side effect improve recovery . PURPOSE : This phase II trial study well intralesional resection work treat patient low-grade chondrosarcoma bone .</brief_summary>
	<brief_title>S0344 Intralesional Resection Treating Patients With Chondrosarcoma Bone</brief_title>
	<detailed_description>OBJECTIVES : - Determine probability local complication ( e.g. , fracture , nerve palsy , deep venous thrombosis , unexpected rehospitalization , unanticipated reoperation , death within 2 year ) patient suspect low-grade intracompartmental chondrosarcoma bone undergoing intralesional resection . - Determine 5-year probability local recurrence development metastatic disease patient undergoing procedure . - Determine impact musculoskeletal tumor reconstruction functional status patient undergoing procedure . OUTLINE : This multicenter study . Patients undergo intralesional resection ( curettage high-speed burr ) . Patients receive local adjuvant treatment comprise liquid nitrogen , phenol , alcohol , argon beam excision site . The bone cavity fill either polymethyacrylate cement bone graft ( allograft homograft ) . Patients may also metal plate instal wound site . Patients follow every 3 month 1 year every 6 month 4 year . PROJECTED ACCRUAL : A total 60 patient accrue study within 30-60 month .</detailed_description>
	<mesh_term>Chondrosarcoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Suspected lowgrade intracompartmental chondrosarcoma , define follow criterion : Resorption prior calcification ( indicated change radiographic appearance time ) AND/OR meet least 2 , 4 , follow criterion : Permeative appearance medullary bone , define presence tumor around 3 side trabecula normal bone Endosteal scalloping , define &gt; 50 % adjacent cortical thickness Cortical thicken beyond thickness adjacent normal bone Bone expansion , define circumferential increase diameter bone beyond adjacent normal bone Positive ( i.e. , increase uptake `` hot '' ) bone scan No cortical disruption and/or soft tissue mass radiography CT scan ( 3 mm cut optimal ) MRI No presumptive axial ( spinal ) involvement No multifocal disease bone scan PATIENT CHARACTERISTICS : Age 18 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer complete remission PRIOR CONCURRENT THERAPY : Biologic therapy No prior biologic therapy tumor Chemotherapy No prior chemotherapy tumor Endocrine therapy Not specify Radiotherapy No prior radiotherapy tumor Surgery No prior surgery tumor except biopsy* No concurrent intramedullary fixation NOTE : *Biopsy require Other No prior investigational anticancer agent tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>chondrosarcoma</keyword>
</DOC>